Cwm LLC Buys 8,524 Shares of GRAIL, Inc. $GRAL

Key Points

• Cwm LLC increased its holdings in GRAIL, Inc. by 37.5%, acquiring an additional 8,524 shares during the second quarter, bringing its total to 31,239 shares valued at approximately $1.6 million.
• President Joshua J. Ofman and CEO Robert P. Ragusa sold significant portions of their shares, with total transactions valued at over $1 million, reflecting a modest decrease in their ownership in the company.
• GRAIL’s stock has seen a 9.7% decline recently, with an average target price set at $56.67 and various analyst ratings ranging from Buy to Sell.

Cwm LLC grew its holdings in shares of GRAIL, Inc. (NASDAQ:GRAL - Free Report) by 37.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 31,239 shares of the company's stock after acquiring an additional 8,524 shares during the period. Cwm LLC owned about 0.09% of GRAIL worth $1,606,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of GRAL. Wealth Enhancement Advisory Services LLC bought a new position in shares of GRAIL during the first quarter valued at $719,000. Oppenheimer & Co. Inc. raised its stake in shares of GRAIL by 19.9% during the first quarter. Oppenheimer & Co. Inc. now owns 12,794 shares of the company's stock valued at $327,000 after acquiring an additional 2,125 shares during the last quarter. S.A. Mason LLC raised its stake in shares of GRAIL by 50.1% during the first quarter. S.A. Mason LLC now owns 1,499 shares of the company's stock valued at $38,000 after acquiring an additional 500 shares during the last quarter. Wealthquest Corp bought a new position in shares of GRAIL during the first quarter valued at $18,247,000. Finally, KBC Group NV raised its stake in shares of GRAIL by 187.7% during the first quarter. KBC Group NV now owns 1,430 shares of the company's stock valued at $37,000 after acquiring an additional 933 shares during the last quarter.

Insider Buying and Selling at GRAIL

In other GRAIL news, President Joshua J. Ofman sold 6,114 shares of GRAIL stock in a transaction on Thursday, October 16th. The shares were sold at an average price of $82.01, for a total value of $501,409.14. Following the completion of the sale, the president directly owned 381,818 shares of the company's stock, valued at approximately $31,312,894.18. The trade was a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Robert P. Ragusa sold 7,239 shares of GRAIL stock in a transaction on Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total transaction of $498,622.32. Following the completion of the sale, the chief executive officer directly owned 727,388 shares of the company's stock, valued at approximately $50,102,485.44. This trade represents a 0.99% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 117,497 shares of company stock valued at $7,515,436.

GRAIL Stock Down 9.7%

Shares of NASDAQ GRAL opened at $78.00 on Monday. GRAIL, Inc. has a twelve month low of $12.76 and a twelve month high of $89.57. The firm has a fifty day simple moving average of $46.19 and a 200 day simple moving average of $40.29. The company has a market capitalization of $2.81 billion, a PE ratio of -5.95 and a beta of 4.11.

GRAIL (NASDAQ:GRAL - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts' consensus estimates of ($3.14) by ($0.04). GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%.The firm had revenue of $35.54 million for the quarter, compared to the consensus estimate of $37.57 million. As a group, equities analysts expect that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

GRAL has been the subject of several analyst reports. Canaccord Genuity Group raised their price target on shares of GRAIL from $43.00 to $75.00 and gave the company a "buy" rating in a research note on Friday, October 3rd. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of GRAIL in a research note on Wednesday, October 8th. Finally, UBS Group set a $75.00 target price on shares of GRAIL in a research note on Friday, October 3rd. One investment analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, GRAIL currently has an average rating of "Hold" and an average target price of $56.67.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.

Want to see what other hedge funds are holding GRAL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GRAIL, Inc. (NASDAQ:GRAL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.